

.png)
A distinctive
pharmaceutical company
Founded in Barcelona in 2003, Galenicum is a global pharmaceutical company dedicated to developing, manufacturing, and commercializing high-quality medicines.
What makes us distinctive is our culture: we are entrepreneurial, fast-moving and build real partnerships on trust. Powered by scientific rigor and ownership on every step of the value chain, we embrace challenges as we expand into increasingly complex pharmaceutical products.
Driven by a mission to improve the quality and affordability of healthcare, Galenicum serves pharmaceutical partners, health systems, and patients across more than 70 countries worldwide.
Our
Business
Marketing Authorisations
131
Active R&D Projects
+30
CAPEX
47M€
Consolidated Revenues
303M€
Countries
73
Employees
+900
Our
Numbers
2025
Pharmacovigilance
Report on suspected adverse drug reactions T +34 932 011 750 - (extension 4) pharmacovigilance@galenicum.com
Compliance
Pharmacovigilance
Report on suspected adverse drug reactions T +34 932 011 750 - (extension 4) pharmacovigilance@galenicum.com
Compliance
Reports
Annual Report 2025
EINF 2024




.png)


